Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03249090 · ClinicalTrials.gov registry record · NA
Electronic Patient Reporting of Symptoms During Cancer Treatment
A NA study, sponsored by Alliance Foundation Trials.
- Completed
- Registry status
- NA
- Development phase
- 1,197
- Enrollment target
NCT03249090: Completed NA study, sponsored by Alliance Foundation Trials.
NCT03249090 is a NA study that has completed, run by Alliance Foundation Trials. The registered enrollment target is 1,197 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (15% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03249090, a NA study, has completed, sponsored by Alliance Foundation Trials.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,197 participants
- Enrollment target
Study Summary
The current study is designed to test nationally whether patients' outcomes and utilization of services can be improved through symptom monitoring via patient-reported outcomes between visits.
Primary Outcome
Unadjusted Kaplan-Meier estimated survival, based on administrative datasets and practice self-report/medical records.
Interventions
- OTHER Patient Self-Reporting of Symptoms
- OTHER Usual Care Delivery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,197 participants |
| Start Date | 2017-10-30 |
| Est. Completion | 2023-08-30 |
| Phase | NA |
What the finished NCT03249090 record still lists
NCT03249090 is an interventional study that assigns participants to a tested intervention. Its 1,197 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (15% lower).
The record links to 0 conditions, and to 2 interventions - of which Patient Self-Reporting of Symptoms is the first listed.
NCT03249090 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03249090 about?
NCT03249090 is a clinical study titled "Electronic Patient Reporting of Symptoms During Cancer Treatment". The current study is designed to test nationally whether patients' outcomes and utilization of services can be improved through symptom monitoring via patient-reported outcomes between visits.
What is the current status of trial NCT03249090?
This trial is currently completed. It is a NA study. The enrollment target is 1,197 participants. The study started on 2017-10-30. Estimated completion is 2023-08-30.
What interventions are being tested in trial NCT03249090?
The interventions under investigation include: Patient Self-Reporting of Symptoms (OTHER), Usual Care Delivery (OTHER).
Who is sponsoring clinical trial NCT03249090?
This trial is sponsored by Alliance Foundation Trials, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03249090's enrollment target sits among peer trials
1,197 89th of 2000 higher than 1,912 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07177339 · 1,196 participants · Phase 3
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
- NCT00001987 · 1,200 participants
Genetic Studies of Insulin and Diabetes
- NCT00477100 · 1,200 participants
Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer
- NCT01209000 · 1,200 participants
Nephrotic Syndrome Study Network
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI